Back to Trades
Total Value
$636.9K
Filing Date
Jun 18, 2026
1 transactions
Trade Summary
On Jun 17, 2026, Resnick Joshua, Director, reported $636.9K of Sionna Therapeutics, Inc. (SION) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $36.73. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Sionna Therapeutics, Inc.
- Ticker Symbol
- SION
- CIK
- 0002036042
Insider Information
- Name
- Resnick Joshua
- Role
- Director
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0001690959-26-000004
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | SION derivative | 17,340 | $36.73 | Grant/Award | $636.9K |
Want live alerts when Resnick Joshua trades again?
Download Insider Trades to track SION, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), the RA Capital Nexus Fund, L.P. (the "Nexus Fund"), the RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund, the Nexus Fund, the Nexus Fund III and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock.
- (F2)This option vests in full upon the earlier of June 17, 2027 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date.